Yinnan Chen
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
EZH2 deficiency suppresses colorectal cancer progression by inhibiting the mismatch repair pathway and consequently reducing extrachromosomal circular DNA formation.
Journal: Cell death & disease
Published: January 17, 2026
Methyltransferase MGMT upregulation drives metastasis by activating epithelial-mesenchymal transition in KRAS mutant colon cancer.
Journal: Cell death & disease
Published: October 14, 2025
Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances.
Journal: Molecular biomedicine
Published: September 18, 2025
Correction: Qiu et al. P53 Deficiency Accelerates Esophageal Epithelium Intestinal Metaplasia Malignancy. Biomedicines 2023, 11, 882.
Journal: Biomedicines
Published: July 04, 2025
Correction to "Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis".
Journal: Molecular pharmaceutics
Published: June 03, 2025
Stearoyl-CoA desaturase 1: An important factor in lipid metabolism in colorectal cancer.
Journal: Biochemical pharmacology
Published: April 29, 2025
Rewiring Tryptophan Metabolism via Programmable Probiotic Integrated by Dual-Layered Microcapsule Protects against Inflammatory Bowel Disease in Mice.
Journal: ACS nano
Published: November 28, 2024
Extrachromosomal circular DNA as a novel biomarker for the progression of colorectal cancer.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 26, 2024
Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis.
Journal: Molecular pharmaceutics
Published: October 28, 2024
Last Updated: 09/26/2026